161
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

SPP1/AnxA1/TIMP1 as Essential Genes Regulate the Inflammatory Response in the Acute Phase of Cerebral Ischemia-Reperfusion in Rats

, , , , , , , ORCID Icon & show all
Pages 4873-4890 | Published online: 24 Aug 2022

References

  • Kim J, Thayabaranathan T, Donnan GA, et al. Global stroke statistics 2019. Int J Stroke. 2020;15(8):819–838. doi:10.1177/1747493020909545
  • Hui C, Tadi P, Patti L. Ischemic stroke. In: StatPearls. Treasure Island (FL); 2021.
  • Musuka TD, Wilton SB, Traboulsi M, Hill MD. Diagnosis and management of acute ischemic stroke: speed is critical. Can Med Assoc J. 2015;187(12):887–893. doi:10.1503/cmaj.140355
  • Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130(6):2777–2788. doi:10.1172/JCI135530
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
  • Rinaldo L, Rabinstein AA, Cloft H, Knudsen JM, Castilla LR, Brinjikji W. Racial and Ethnic Disparities in the Utilization of Thrombectomy for acute stroke. Stroke. 2019;50(9):2428–2432. doi:10.1161/STROKEAHA.118.024651
  • Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6(1):11. doi:10.1186/1750-1326-6-11
  • Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - The ischemic penumbra. Stroke. 1981;12(6):723–725. doi:10.1161/01.STR.12.6.723
  • Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181–198. doi:10.1016/j.neuron.2010.07.002
  • Weinstein PR, Hong S, Sharp FR. Molecular identification of the ischemic penumbra. Stroke. 2004;35(11 Suppl 1):2666–2670. doi:10.1161/01.STR.0000144052.10644.ed
  • Hu XM, Li PY, Guo YL, Wang HY, Gao YQ, Chen J. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral Ischemia. Stroke. 2013;44:2. doi:10.1161/str.44.suppl_1.AWP98
  • Liu ZW, Li Y, Cui YS, et al. Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke. Glia. 2014;62(12):2022–2033. doi:10.1002/glia.22723
  • Ellison JA, Barone FC, Feuerstein GZ. Matrix remodeling after stroke - De Novo expression of matrix proteins and integrin receptors. Ann Ny Acad Sci. 1999;890:204–222. doi:10.1111/j.1749-6632.1999.tb07996.x
  • Maida CD, Norrito RL, Daidone M, Tuttolomondo A, Pinto A. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. 2020;21:18. doi:10.3390/ijms21186454
  • Del Giacco L, Cattaneo C. Introduction to genomics. Methods in Molecular Biology. 2012;823:79–88.
  • Chen G, Li L, Tao H. Bioinformatics identification of ferroptosis-related biomarkers and therapeutic compounds in ischemic Stroke. Front Neurol. 2021;12:745240. doi:10.3389/fneur.2021.745240
  • Deng GX, Xu N, Huang Q, et al. Association between promoter DNA methylation and gene expression in the pathogenesis of ischemic stroke. Aging (Albany NY). 2019;11(18):7663–7677. doi:10.18632/aging.102278
  • Xiao X, Bai P, Cao S, et al. Integrated bioinformatics analysis for the identification of key molecules and pathways in the hippocampus of rats after traumatic brain injury. Neurochem Res. 2020;45(4):928–939. doi:10.1007/s11064-020-02973-9
  • Pluta R, Januszewski S, Czuczwar SJ. Neuroinflammation in post-ischemic neurodegeneration of the brain: friend, foe, or both? Int J Mol Sci. 2021;22:9. doi:10.3390/ijms22094405
  • Radenovic L, Nenadic M, Ulamek-Koziol M, et al. Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer’s disease after 2 years of survival. Aging (Albany NY). 2020;12(12):12251–12267. doi:10.18632/aging.103411
  • Li G, Morris-Blanco KC, Lopez MS, et al. Impact of microRNAs on ischemic stroke: from pre- to post-disease. Prog Neurobiol. 2018;163–164:59–78. doi:10.1016/j.pneurobio.2017.08.002
  • Howells DW, Porritt MJ, Rewell SSJ, et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cerebr Blood F Met. 2010;30(8):1412–1431. doi:10.1038/jcbfm.2010.66
  • Fluri F, Schuhmann MK, Kleinschnitz C. Animal models of ischemic stroke and their application in clinical research. Drug Des Dev Ther. 2015;9:3445–3454.
  • Wang L, Yu Y, Yang J, Zhao X, Dissecting Xuesaitong’s LZ. mechanisms on preventing stroke based on the microarray and connectivity map. Mol Biosyst. 2015;11(11):3033–3039. doi:10.1039/C5MB00379B
  • Takuma A, Saito Y, Abe A, Asakura T, Abe K. Expression data from MCAO or Sham operated rat brain [mRNA]; 2018.
  • Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846–1847. doi:10.1093/bioinformatics/btm254
  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
  • Sommer CJ. Ischemic stroke: experimental models and reality. Acta Neuropathol. 2017;133(2):245–261. doi:10.1007/s00401-017-1667-0
  • Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91. doi:10.1161/01.STR.20.1.84
  • Lo JW, Crawford JD, Desmond DW, et al. profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups. Neurology. 2019;93(24):e2257–e2271. doi:10.1212/WNL.0000000000008612
  • Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflamm. 2019;16:1–24.
  • Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808. doi:10.1038/nm.2399
  • Jin R, Liu L, Zhang S, Nanda A, Li G. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013;6(5):834–851. doi:10.1007/s12265-013-9508-6
  • Huang R, Ma J, Niu B, et al. MiR-34b protects against focal cerebral Ischemia-Reperfusion (I/R) injury in rat by targeting keap1. J Stroke Cerebrovasc. 2019;28(1):1–9. doi:10.1016/j.jstrokecerebrovasdis.2018.08.023
  • Yin KJ, Deng Z, Hamblin M, et al. Peroxisome proliferator-activated receptor delta regulation of miR-15a in Ischemia-induced cerebral vascular endothelial injury. J Neurosci. 2010;30(18):6398–6408. doi:10.1523/JNEUROSCI.0780-10.2010
  • Liu P, Zhao HP, Wang RL, et al. MicroRNA-424 protects against focal cerebral ischemia and reperfusion injury in mice by suppressing oxidative stress. Stroke. 2015;46(2):513–519. doi:10.1161/STROKEAHA.114.007482
  • Xu L-J, Ouyang Y-B, Xiong XX, Stary CM, Giffard RG. Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia. Exp Neurol. 2015;264:1–7. doi:10.1016/j.expneurol.2014.11.007
  • Yoo H, Kim J, Lee AR, et al. Alteration of microRNA 340-5p and Arginase-1 expression in peripheral blood cells during acute ischemic stroke. Mol Neurobiol. 2019;56(5):3211–3221. doi:10.1007/s12035-018-1295-2
  • Wang J, Liu GZ. Protective effect of microRNA-340-5p against oxygen-glucose deprivation/reperfusion in PC12 cells through targeting neuronal differentiation 4. Mol Med Rep. 2020;22(2):964–974. doi:10.3892/mmr.2020.11174
  • Wang X, Louden C, Yue TL, et al. Delayed expression of osteopontin after focal stroke in the rat. J Neurosci. 1998;18(6):2075–2083. doi:10.1523/JNEUROSCI.18-06-02075.1998
  • Doyle KP, Yang T, Lessov NS, et al. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J Cereb Blood Flow Metab. 2008;28(6):1235–1248. doi:10.1038/jcbfm.2008.17
  • Jing M, Li B, Hou X, et al. OPN gene polymorphism and the serum OPN levels confer the susceptibility and prognosis of ischemic stroke in Chinese patients. Cell Physiol Biochem. 2013;32(6):1798–1807. doi:10.1159/000356613
  • Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000;19(7):615–622. doi:10.1016/S0945-053X(00)00108-6
  • Berglund LM, Lyssenko V, Ladenvall C, et al. Glucose-dependent insulinotropic polypeptide stimulates osteopontin expression in the vasculature via endothelin-1 and CREB. Diabetes. 2016;65(1):239–254. doi:10.2337/db15-0122
  • Carbone F, Vuilleumier N, Burger F, et al. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke. Eur J Clin Invest. 2015;45(6):579–586. doi:10.1111/eci.12446
  • Cuadrado E, Rosell A, Penalba A, et al. Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein Array Study. J Proteome Res. 2009;8(6):3191–3197. doi:10.1021/pr801012x
  • Zhong. Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke (vol 93, pg e1675, 2019). Neurology. 2019;93(18):819.
  • Senchenkova EY, Ansari J, Becker F. Novel role for the AnxA1-Fpr2/ALX signaling axis as a key regulator of platelet function to Promote Resolution of Inflammation. Circulation. 2019;1404:E172–E172.
  • Datta A, Akatsu H, Heese K, Sze SK. Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology. J Proteomics. 2013;91:556–568. doi:10.1016/j.jprot.2013.08.017
  • Li X, Zheng L, Xia Q, et al. A novel cell-penetrating peptide protects against neuron apoptosis after cerebral ischemia by inhibiting the nuclear translocation of annexin A1. Cell Death Differ. 2019;26(2):260–275. doi:10.1038/s41418-018-0116-5
  • Xia Q, Li X, Zhou HJ, Zheng L, Shi J. S100A11 protects against neuronal cell apoptosis induced by cerebral ischemia via inhibiting the nuclear translocation of annexin A1. Cell Death Dis. 2018;9:1–7.
  • Zheng YK, Zhao P, Lian YJ, Li S, Chen Y, Li LH. MiR-340-5p alleviates oxygen-glucose deprivation/reoxygenation-induced neuronal injury via PI3K/Akt activation by targeting PDCD4. Neurochem Int. 2020;134:104650.
  • Del Zoppo GJ. The neurovascular unit in the setting of stroke. J Intern Med. 2010;267(2):156–171. doi:10.1111/j.1365-2796.2009.02199.x
  • Cristante E, McArthur S, Mauro C, et al. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. P Natl Acad Sci USA. 2013;110(3):832–841. doi:10.1073/pnas.1209362110
  • Shen X, Zhang S, Guo Z, Xing DM, Chen WJ. The crosstalk of ABCA1 and ANXA1: a potential mechanism for protection against atherosclerosis. Mol Med. 2020;26:1. doi:10.1186/s10020-020-00213-y
  • Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018;59:17–24. doi:10.1016/j.clinbiochem.2018.07.003
  • Meller R, Stevens SL, Minami M, et al. Neuroprotection by osteopontin in stroke. J Cerebr Blood F Met. 2005;25(2):217–225. doi:10.1038/sj.jcbfm.9600022